Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta‐analysis of short‐term outcome
- 5 March 2012
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 14 (4), e134-e156
- https://doi.org/10.1111/j.1463-1318.2011.02907.x
Abstract
The study aimed to compare robotic rectal resection with laparoscopic rectal resection for cancer. Robotic surgery has been used successfully in many branches of surgery but there is little evidence in the literature on its use in rectal cancer. We performed a systematic review of the available literature in order to evaluate the feasibility, safety and effectiveness of robotic versus laparoscopic surgery for rectal cancer. We compared robotic and laparoscopic surgery with respect to twelve end-points including operative and recovery outcomes, early postoperative mortality and morbidity, and oncological parameters. A subgroup analysis of patients undergoing full-robotic or robot-assisted rectal resection and robotic total mesorectal excision was carried out. All aspects of Cochrane Handbook for systematic reviews and Preferred Reporting Items for Systematic Reviews and Metanalysis (PRISMA) statement were followed to conduct this systematic review. Comprehensive electronic search strategies were developed using the following electronic databases: PubMed, EMBASE, OVID, Medline, Cochrane Database of Systematic Reviews, EBM reviews and CINAHL. Randomized and nonrandomized clinical trials comparing robotic and laparoscopic resection for rectal cancer were included. No language or publication status restrictions were imposed. A data-extraction sheet was developed based on the data extraction template of the Cochrane Group. The statistical analysis was performed using the odd ratio (OR) for categorical variables and the weighted mean difference (WMD) for continuous variables. Eight non randomized studies were identified that included 854 patients in total, 344 (40.2%) in the robotic group and 510 (59.7%) in the laparoscopic group. Meta-analysis suggested that the conversion rate to open surgery in the robotic group was significantly lower than that with laparoscopic surgery (OR = 0.26, 95% CI: 0.12-0.57, P = 0.0007). There were no significant differences in operation time, length of hospital stay, time to resume regular diet, postoperative morbidity and mortality, and the oncological accuracy of resection. Robotic surgery for rectal cancer has a lower conversion rate and a similar operative time compared with laparoscopic surgery, with no difference in recovery, oncological and postoperative outcomes.Keywords
This publication has 56 references indexed in Scilit:
- Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched studySurgical Endoscopy, 2010
- Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trialThe Lancet Oncology, 2010
- S052: a comparison of robot-assisted, laparoscopic, and open surgery in the treatment of rectal cancerSurgical Endoscopy, 2010
- Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomesSurgical Endoscopy, 2010
- Oncologic Outcomes of Robotic-Assisted Total Mesorectal Excision for the Treatment of Rectal CancerAnnals of Surgery, 2010
- Laparoscopic and robot-assisted one-stage resection of colorectal cancer with synchronous liver metastases: a pilot studyJournal of Hepato-Biliary-Pancreatic Surgery, 2009
- Robotic tumor-specific mesorectal excison of rectal cancer: short-term outcome of a pilot randomized trialSurgical Endoscopy, 2008
- Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancerSurgical Endoscopy, 2006
- Laparoscopic Colon Surgery: Past, Present and FutureSurgical Clinics of North America, 2006
- Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trialThe Lancet, 2005